Baillie Gifford & CO Axogen, Inc. Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$7.26 - $10.7 $1.82 Million - $2.69 Million	-250,991 Reduced 99.82%	444 $4,000
Q4 2021 Jan 20, 2022	SELL	$8.8 - $16.0 $8.01 Million - $14.6 Million	-910,224 Reduced 78.36%	251,435 $2.36 Million
Q3 2021 Oct 19, 2021	SELL	$15.23 - $21.72 $69,722 - $99,434	-4,578 Reduced 0.39%	1,161,659 $18.4 Million
Q2 2021 Aug 02, 2021	SELL	$17.8 - $23.5 $97,846 - $129,179	-5,497 Reduced 0.47%	1,166,237 $25.2 Million
Q1 2021 May 06, 2021	BUY	$17.18 - $22.6 $171,490 - $225,593	9,982 Added 0.86%	1,171,734 $23.7 Million
Q4 2020 Feb 10, 2021	BUY	$11.5 - $17.96 $932,282 - $1.46 Million	81,068 Added 7.5%	1,161,752 $20.8 Million
Q3 2020 Nov 12, 2020	SELL	$10.62 - $13.12 $4,757 - $5,877	-448 Reduced 0.04%	1,080,684 $12.6 Million
Q2 2020 Aug 12, 2020	BUY	$7.35 - $10.81 $283,724 - $417,287	38,602 Added 3.7%	1,081,132 $9.99 Million
Q1 2020 May 08, 2020	BUY	$8.38 - $17.34 $90,612 - $187,497	10,813 Added 1.05%	1,042,530 $10.8 Million
Q4 2019 Feb 10, 2020	BUY	$11.18 - $18.6 $473,104 - $787,096	42,317 Added 4.28%	1,031,717 $18.5 Million
Q3 2019 Nov 07, 2019	BUY	$12.09 - $20.46 $174,096 - $294,624	14,400 Added 1.48%	989,400 $12.3 Million
Q2 2019 Aug 08, 2019	SELL	$18.5 - $25.47 $105,450 - $145,179	-5,700 Reduced 0.58%	975,000 $19.3 Million
Q1 2019 May 01, 2019	BUY	$14.62 - $22.13 $5.03 Million - $7.61 Million	343,900 Added 54.0%	980,700 $0
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $10.7 Million - $23.9 Million	624,032 Added 4887.47%	636,800 $13 Million
Q3 2018 Nov 13, 2018	BUY	$34.05 - $55.9 $434,750 - $713,731	12,768 New	12,768 $471,000

Others Institutions Holding AXGN

# of Institutions

165

Shares Held

36.1M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$74.5 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$59.2 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$54.7 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$52.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$44.2 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $770M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account